Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats

Hypertension

Volumn 65, Issue 3, 2015, Pages 676-682

  Stott, Jennifer B ^a   Barrese, Vincenzo ^a   Jepps, Thomas A ^b   Leighton, Emma V ^a   Greenwood, Iain A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cyclic GMP; KCNQ potassium channels; muscle, smooth, vascular; natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; LINOPIRDINE; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONAMIDE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; CHROMAN DERIVATIVE; INDOLE DERIVATIVE; KCNQ4 PROTEIN, RAT; NATRIURETIC FACTOR; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ1; PYRIDINE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTENSION; NONHUMAN; POLYMERASE CHAIN REACTION; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ANIMALS; AORTA; CHROMANS; CYCLIC GMP; DISEASE MODELS, ANIMAL; HYPERTENSION; INDOLES; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; MALE; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDES; NITROPRUSSIDE; POTASSIUM CHANNEL BLOCKERS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, WISTAR; RENAL ARTERY; SIGNAL TRANSDUCTION; SULFONAMIDES; VASODILATION;

EID: 84924099164     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04373     Document Type: Article

References (25)

1. Morgado M, Cairrão E, Santos-Silva AJ, Verde I. Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell Mol Life Sci. 2012;69:247-266. doi: 10.1007/s00018-011-0815-2.
2. Potter LR. Guanylyl cyclase structure, function and regulation. Cell Signal. 2011;23:1921-1926. doi: 10.1016/j.cellsig.2011.09.001.
3. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27:47-72. doi: 10.1210/er.2005-0014.
4. Pandey KN. Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation. J Am Soc Hypertens. 2008;2:210-226. doi: 10.1016/j.jash.2008.02.001.
5. Lumsden NG, Khambata RS, Hobbs AJ. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des. 2010;16:4080-4088.
6. Greenwood IA, Ohya S. New tricks for old dogs: KCNQ expression and role in smooth muscle. Br J Pharmacol. 2009;156:1196-1203. doi: 10.1111/j.1476-5381.2009.00131.x.
7. Stott JB, Jepps TA, Greenwood IA. K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders. Drug Discov Today. 2014;19:413-424. doi: 10.1016/j.drudis.2013.12.003.
8. Chadha PS, Jepps TA, Carr G, Stott JB, Zhu HL, Cole WC, Greenwood IA. Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity. Arterioscler Thromb Vasc Biol. 2014;34:887-893. doi: 10.1161/ATVBAHA.114.303405.
9. Brueggemann LI, Mackie AR, Cribbs LL, Freda J, Tripathi A, Majetschak M, Byron KL. Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem. 2014;289:2099-2111. doi: 10.1074/jbc.M113.527820.
10. Yeung SY, Pucovský V, Moffatt JD, Saldanha L, Schwake M, Ohya S, Greenwood IA. Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol. 2007;151:758-770. doi: 10.1038/sj.bjp.0707284.
11. Joshi S, Balan P, Gurney AM. Pulmonary vasoconstrictor action of KCNQ potassium channel blockers. Respir Res. 2006;7:31. doi: 10.1186/1465-9921-7-31.
12. Jepps TA, Chadha PS, Davis AJ, Harhun MI, Cockerill GW, Olesen SP, Hansen RS, Greenwood IA. Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation. 2011;124:602-611. doi: 10.1161/CIRCULATIONAHA.111.032136.
13. Chadha PS, Zunke F, Zhu HL, Davis AJ, Jepps TA, Olesen SP, Cole WC, Moffatt JD, Greenwood IA. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension. Hypertension. 2012;59:877-884. doi: 10.1161/HYPERTENSIONAHA.111.187427.
14. Khanamiri S, Soltysinska E, Jepps TA, Bentzen BH, Chadha PS, Schmitt N, Greenwood IA, Olesen SP. Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension. 2013;62:1090-1097. doi: 10.1161/HYPERTENSIONAHA.113.01244.
15. Brueggemann LI, Haick JM, Neuburg S, Tate S, Randhawa D, Cribbs LL, Byron KL. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways. Am J Physiol Lung Cell Mol Physiol. 2014;306:L476-L486. doi: 10.1152/ajplung.00253.2013.
16. + (BK(Ca)) channels to the relaxation of guinea-pig aorta in response to natriuretic peptides. J Smooth Muscle Res. 2002;38:117-129.
17. Tanaka Y, Tang G, Takizawa K, Otsuka K, Eghbali M, Song M, Nishimaru K, Shigenobu K, Koike K, Stefani E, Toro L. Kv channels contribute to nitric oxide- and atrial natriuretic peptide-induced relaxation of a rat conduit artery. J Pharmacol Exp Ther. 2006;317:341-354. doi: 10.1124/jpet.105.096115.
18. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A. 2003;100:1426-1431. doi: 10.1073/pnas.0336365100.
19. Sandow SL, Tare M. C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor? Trends Pharmacol Sci. 2007;28:61-67. doi: 10.1016/j.tips.2006.12.007.
20. Garland CJ, Dora KA. Evidence against C-type natriuretic peptide as an arterial 'EDHF'. Br J Pharmacol. 2008;153:4-5. doi: 10.1038/sj.bjp.0707520.
21. Leuranguer V, Vanhoutte PM, Verbeuren T, Félétou M. C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol. 2008;153:57-65. doi: 10.1038/sj.bjp.0707476.
22. Wei CM, Hu S, Miller VM, Burnett JC Jr. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun. 1994;205:765-771.
23. Garcha RS, Hughes AD. CNP, but not ANP or BNP, relax human isolated subcutaneous resistance arteries by an action involving cyclic GMP and BKCa channels. J Renin Angiotensin Aldosterone Syst. 2006;7:87-91. doi: 10.3317/jraas.2006.014.
24. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853. doi: 10.1038/368850a0.
25. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol. 1998;124:1131-1140. doi: 10.1038/sj.bjp.0701940.